Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases

Neurotoxicity Research

Volumn 30, Issue 1, 2016, Pages 41-52

  Costa, Silvia Lima ^a   Silva, Victor Diogenes Amaral ^a   dos Santos Souza, Cleide ^a   Santos, Cleonice Creusa ^a   Paris, Irmgard ^b,c   Muñoz, Patricia ^b   Segura Aguilar, Juan ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD SANTO TOMÁS   (Chile)

Author keywords

Astrocytes; Flavonoids; Microglia; Neuroprotection; Neuroritogenesis

Indexed keywords

APIGENIN; AURANTIIN; BAICALEIN; DEFEROXAMINE; FLAVONOID; NARINGENIN; QUERCETIN; RUTOSIDE; SILYMARIN; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; ASTROCYTE; CAESALPINIA PYRAMIDALIS; CROTON BETULASTER; DEGENERATIVE DISEASE; DIMORPHANDRA MOLLIS; DOSE RESPONSE; DRUG STRUCTURE; EMBRYONIC STEM CELL; GLIA CELL; HUMAN; HYPERTENSION; INSOMNIA; MEDICINAL PLANT; MICROGLIA; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEURALGIA; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; POINCIANELLA PYRAMIDALIS; PRIORITY JOURNAL; SCOPOLAMINE-INDUCED AMNESIA; VASCULAR DISEASE; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; NERVE CELL; NEURODEGENERATIVE DISEASES; PLANT;

ANIMALS; CELLS, CULTURED; FLAVONOIDS; HUMANS; MICROGLIA; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; PLANTS;

EID: 84960127615     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-016-9600-1     Document Type: Article

References (157)

1. Aguiar A et al (2013) Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurotox Res 24:280–287
2. Aguiar A et al (2014) Six weeks of voluntary exercise don’t protect C57BL/6 mice against neurotoxicity of MPTP and MPP(+). Neurotox Res 25:147–152
3. Aguirre P, Urrutia P, Tapia V, Villa M, Paris I, Segura-Aguilar J, Núñez M (2012) The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1. Biometals 25:795–803
4. Ahmad A, Maruyama T, Narumiya S, Doré S (2013) PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target. Neurotox Res 23:260–266
5. Anandhan A, Essa M, Manivasagam T (2013) Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson’s disease. Neurotox Res 23:166–173
6. Andrade J, Assunção M (2012) Protective effects of chronic green tea consumption on age-related neurodegeneration. Curr Pharm Des 18:4–14
7. Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe W (2009) A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease. Lancet Neurol 8:929–937
8. Archer T, Fredriksson A (2013) The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice. Neurotox Res 24:393-406
9. Arriagada A et al (2004) On the neurotoxicity of leukoaminochrome o-semiquinone radical derived of dopamine oxidation: mitochondria damage, necrosis and hydroxyl radical formation. Neurobiol Dis 16(16):468–477
10. Aschner M, Allen J, Kimelberg H, LoPachin R, Streit W (1999) Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 39:151–173
11. Azevedo M et al (2013) The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol Pain 23:53. doi:10.1186/1744-8069-9-53
12. Aziza SA, Azab Mel-S, ElShall SK (2014) Ameliorating role of rutin on oxidative stress induced by iron overload in hepatic tissue of rats. Asian Netw Sci Inform 17:13
13. Baluchnejadmojarad T, Roghani M, Mafakheri M (2010) Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett 23:206–210
14. Becho JRM, Machado H, Guerra MO (2009) Rutina: estrutura, metabolismo e potencial farmacológico. Revista Interdisciplinar de Estudos Experimentais 1:4
15. Beking A, Vieira K (2010) Flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr 13:1403–1409. doi:10.1017/S1368980009992990
16. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Tredici KD (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134
17. Cabezas R, Avila M, González J, El-Bachá R, Barreto G (2014) PDGF-BB Protects Mitochondria from Rotenone in T98G Cells. Neurotox Res 74:80–90
18. Caruana M, Högen T, Levin J, Hillmer A, Giese A, Vassallo N (2011) Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds. FEBS Lett 585:1113–1120. doi:10.1016/j.febslet.2011.03.046
19. Chanet A, Milenkovic D, Manach C, Mazur A, Morand C (2012) Citrus flavanones: what is their role in cardiovascular protection? J Agric Food Chem 60:8809–8822
20. Chao S, Huang S, Hu DN, Lin H-Y (2013) Subtoxic Levels of apigenin inhibit expression and secretion of vegf by uveal melanoma cells via suppression of ERK1/2 and PI3K/Akt pathways. Evid Based Complement Alternat Med 2013:817674
21. Chen J et al (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11:943–953
22. Choi SKCC, Cho YH, Choi KH, Chang J, Park MS, Kim MK, Cho KH, Kim JK (2014) Effects of flavonoid compounds on β-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam Med J 50:7. doi:10.4068/cmj.2014.50.2.45
23. Choi W, Kim H, Xia Z (2015) JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death. Toxicology 328:75–81
24. Chtourou Y, Trabelsi K, Fetoui H, Mkannez G, Kallel H, Zeghal N (2011) Manganese induces oxidative stress, redox state unbalance and disrupts membrane bound ATPases on murine neuroblastoma cells in vitro: protective role of silymarin. Neurochem Res 36:1546–1557
25. Costa S et al (2002) Astroglial permissivity for neuritic outgrowth in neuron-astrocyte cocultures depends on regulation of laminin bioavailability. Glia 37:105–113. doi:10.1002/glia.10015
26. Członkowska A, Kurkowska-Jastrzebska I, Członkowski A, Peter D, Stefano G (2002) Immune processes in the pathogenesis of Parkinson’s disease - a potential role for microglia and nitric oxide. Med Sci Monit 8:165–177
27. Dajas F et al (2003) Neuroprotection by flavonoids. Braz J Med Biol Res 36:1613–1620
28. de Sampaio e Spohr TC et al (2010) Effects of the flavonoid casticin from Brazilian Croton betulaster in cerebral cortical progenitors in vitro: direct and indirect action through astrocytes. J Neurosci Res 88:530–541. doi:10.1002/jnr.22218
29. Del-Bel E et al (2014) Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment. Neurotox Res 25:35–44
30. Ebrahimi-Fakhari D, Wahlster L, McLean P (2012) Protein degradation pathways in Parkinson’s disease: curse or blessing. Acta Neuropathol 124:153–172
31. Echeverry C, Arredondo F, Abin-Carriquiry J, Midiwo J, Ochieng C, Kerubo L, Dajas F (2010) Pretreatment with natural flavones and neuronal cell survival after oxidative stress: a structure-activity relationship study. J Agric Food Chem 58:2111–2115. doi:10.1021/jf902951v
32. ElMassri N et al (2015) The effect of different doses of near infrared light on dopaminergic cell survival and gliosis in MPTP-treated mice. Int J Neurosci 126:76–87
33. Engelhart M, Geerlings M, Ruitenberg A, Swieten JV, Hofman A, Witteman J, Breteler M (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Assoc 287:3223–3229. doi:10.1001/jama.287.24.3223
34. Exner N, Lutz A, Haass C, Winklhofer K (2012) Mitochondrial dysfunction in Parkinson’s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31:3038–3062
35. Féres CA, Madalosso RC, Roch OA, Leite JPV, Guimarãesa TMDP, Toledoa VPP, Tagliatia CA (2006) Acute and chronic toxicological studies of Dimorphandra mollis in experimental animals. J Ethnopharmacol 108:6. doi:10.1016/j.jep.2006.06.002
36. Fiorani M, Guidarelli A, Blasa M, Azzolini C, Candiracci M, Piatti E, Cantoni O (2010) Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J Nutr Biochem 21:397–404. doi:10.1016/j.jnutbio.2009.01.014
37. Frank-Cannon T, Alto L, McAlpine F, Tansey M (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4:47–60. doi:10.1186/1750-1326-4-47
38. Freitas SCS, Azevedo C, Carvalho G, Freire S, Barbosa P, Velozo E, Schaer R, Tardy M, Meyer R, Nascimento I (2010) Flavonoids inhibit angiogenic cytokine production by human glioma cells. Phytother Res 25:5. doi:10.1002/ptr.3338
39. Geed M, Garabadu D, Ahmad A, Krishnamurthy S (2014) Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats. Pharmacol Biochem Behav 117:92–103
40. Ghofrani S, Joghataei M, Mohseni S, Baluchnejadmojarad T, Bagheri M, Khamse S, Roghani M (2015) Naringenin improves learning and memory in an Alzheimer’s disease rat model: Insights into the underlying mechanisms. Eur J Pharmacol 5:195–201
41. Giulian D, Li J, Leara B, Keenen C (1994) Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem Int 25:227–233
42. Glass C, Saijo K, Winner B, Marchetto M, Gage F (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918–934
43. Gołembiowska K, Dziubina A (2012) Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats. Neurotox Res 21:222–230
44. Gołembiowska K, Wardas J, Noworyta-Sokołowska K, Kamińska K, Górska A (2013) Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease. Neurotox Res 24:29–40
45. Guardia T, Rotelli A, Juarez A, Pelzer L (2001) Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56:683–687. doi:10.1016/S0014-827X(01)01111-9
46. Haddadi R, Nayebi A, Farajniya S, Brooshghalan S, Sharifi H (2014) Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study. Daru. doi:10.1186/2008-2231-22-38
47. Haleagrahara N, Siew C, Ponnusamy K (2013) Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. J Toxicol Sci 38:25–33
48. Hampel H et al (2010) Biological markers of amyloid beta-related mechanisms in Alzheimer’s disease. Exp Neurol 223:334–346
49. Hatten ME (2002) New directions in neuronal migration. Science 297:1660–1663
50. Heo H et al (2004) Naringenin from citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement Geriatr Cogn Disord 17:151–157
51. Hirsch E, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397
52. Hong D, Fink A, Uversky V (2008) Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein. J Mol Biol 383:214–223. doi:10.1016/j.jmb.2008.08.039
53. Huenchuguala S et al (2014) Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction. Autophagy 10:1–13
54. Iqbal K, Liu F, Gong C, IG-I I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7:656–664
55. Jagetia G, Reddy T (2002) The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study. Mutat Res 519:37–48
56. Jamila NKM, Khan SN, Khan N (2014) Complete NMR assignments of bioactive rotameric (3 [RIGHTWARDS ARROW] 8) biflavonoids from the bark of Garcinia hombroniana. Magn Reson Chem 57:7. doi:10.1002/mrc.4071
57. Janssen C et al (2015) Effect of perinatally supplemented flavonoids on brain structure, circulation, cognition, and metabolism in C57BL/6J mice. Neurochem Int 89:157–169. doi:10.1016/j.neuint.2015.05.002
58. Javed H et al (2012) Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 210:340–352
59. Johnston KM, Stern DJ, Walss AC Jr (1968) Separation of flavonoid compounds on Sephadex LH-20. J Chromatog 33:9. doi:10.1016/S0021-9673(00)98686-2
60. Jones Q, Warford J, Rupasinghe H, Robertson G (2012) Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci 33:602–610
61. Ju S, Kang J, Bae J, Pae H, Lyu Y, Jeon B (2015) The flavonoid apigenin ameliorates cisplatin-induced nephrotoxicity through reduction of p53 activation and promotion of PI3KAkt pathway in human renal proximal tubular epithelial cells. Evid Based Complement Alternat Med
62. +-induced neurotoxicity in the substantia nigra in vivo. J Med Food 17:599–605
63. Kabadere S, Oztopcu-Vatan P, Uyar R, Durmaz R (2011) Quercetin both partially attenuates hydrogen peroxide-induced toxicity and decreases viability of rat glial cells. Acta Biol Hung 62:221–227. doi:10.1556/ABiol.62.2011.3.1
64. Kalia L, Kalia S, McLean P, Lozano A, Lang A (2013) α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 73:155–169
65. Kandaswami C, Middleton E (1994) Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 366:351–372
66. Karuppagounder S, Madathil S, Pandey M, Haobam R, Rajamma U, Mohanakumar K (2013) Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats. Neuroscience 236:136–148. doi:10.1016/j.neuroscience.2013.01.032
67. Khan M et al (2012) Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem Int 61:1081–1093
68. Kim H, Song J, Park H, Park H, Yun D, Chung J (2009) Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y Cells. Korean J Physiol Pharmacol 13:281–285
69. Kostka M et al (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283:10992–11003. doi:10.1074/jbc.M709634200
70. Ku SLI, Han M, Bae J (2014) Inhibitory effects of rutin on the endothelial protein c receptor shedding in vitro and in vivo. Inflammation 37:8. doi:10.1007/s10753-014-9866-5
71. Kumar S, Pandey A (2013) Chemistry and biological activities of flavonoids: an overview. Sci World J. doi:10.1155/2013/162750
72. Lao C, Kuo Y, Hsieh Y, Chen J (2013) Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice. Neurotox Res 24:523–531
73. Lee H et al (2005) Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Eur J Cell Biol 84:897–905
74. Lee E, Park H, Ji S, Lee Y, Lee J (2014) Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson’s disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK. J Neurosci Res 2:130–139
75. Lee Y, Park H, Chun H, Lee J (2015) Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease via mitochondrial stabilization. J Neurosci Res 93:755–765
76. Leem E et al (2014) Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson’s disease. J Nutr Biochem 25(27):801–806
77. Liu J et al (2010) A new flavonoid from Selaginella tamariscina (Beauv.) Spring. Chem Pharm Bull (Tokyo) 58:549–551
78. Lopes F et al (2012) Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine. Neurotox Res 22:138–149
79. Lorrio S, Sobrado M, Arias E, Roda J, García A, López M (2007) Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils. J Pharmacol Exp Ther 322:591–599. doi:10.1124/jpet.107.122747
80. Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X (2013) Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway. Neuropharmacology 79:380–388
81. Lu P et al (2009) Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 57:1270–1277
82. Magalingam K, Radhakrishnan A, Haleagrahara N (2013) Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int J Mol Med 32:235–240. doi:10.3892/ijmm.2013.1375
83. Magalingam KB, Radhakrishnan AK, Haleagrahara N (2015) Protective mechanisms of flavonoids in Parkinson’s disease. Oxid Med Cell Longev. doi:10.1155/2015/314560
84. Martinez R, Gomes F (2002) Neuritogenesis induced by thyroid hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase-phosphatidylinositol 3-kinase pathways and involves modulation of extracellular matrix proteins. J Biol Chem 277:49311–49318
85. Martinez-Vicente M, Vila M (2013) Alpha-synuclein and protein degradation pathways in Parkinson’s disease: A pathological feed-back loop. Exp Neurol 247:308–311
86. Mascaraquea CAC, Ocóna B, Montec MJ, Suárezb MD, Zarzueloa A, Marínc JJG, Martínez-Augustinb O, Medina FS (2014) Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ Tcell transfer model of colitis. Pharmacol Res 90:9
87. Masoudi N, Ibanez-Cruceyra P, Offenburger S, Holmes A, Gartner A (2014) Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans. PLoS Genet 10:e1004767
88. McGeer P, Itagaki S, Akiyama H, McGeer E (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574–576
89. Mecocci P, Tinarelli C, Schulz R, Polidori M (2014) Nutraceuticals in cognitive impairment and Alzheimer’s disease. Front Pharmacol 5:147
90. Mercado G, Valdés P, Hetz C (2013) An ERcentric view of Parkinson’s disease. Trends Mol Med 19:165–173
91. Mikia K et al (2007) Anti-influenza virus activity of biflavonoids. Bioorg Med Chem Lett 17:772–775. doi:10.1016/j.bmcl.2006.10.075
92. Moghbelinejad S et al (2014) Rutin activates the MAPK pathway and BDNF gene expression on beta-amyloid induced neurotoxicity in rats. Toxicol Lett 224:108–113
93. Mullen W, Borges G, Lean M, Roberts S, Crozier A (2010) Identification of metabolites in human plasma and urine after consumption of a polyphenol-rich juice drink. J Agric Food Chem 58:2586–2595
94. Munafó D, Colombo M (2001) A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation Journal of Cell Science 114:3619–3629
95. Muñoz P, Cardenas S, Huenchuguala S, Briceño A, Couve E, Paris I, Segura-Aguilar J (2015) DT-diaphorase prevents aminochrome-induced alpha-synuclein oligomer formation and neurotoxicity. Toxicol Sci. doi:10.1093/toxsci/kfv016
96. Murakami S, Miyazak I, Sogawa N, Miyoshi K, Asanuma M (2014) Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice. Neurotox Res Neurotox Res 26:285–298
97. Nadarajah B, Alifragis P, Wong R, Parnavelas J (2003) Neuronal migration in the developing cerebral cortex: observations based on real-time imaging. Cereb Cortex 13:607–611. doi:10.1093/cercor/13.6.607
98. Nadkarni S, Jung P, Levine H (2008) Astrocytes optimize the synaptic transmission of information. PLoS Comput Biol 4:e1000088. doi:10.1371/annotation/ec07378d-fd1b-45b8-bfed-1a20c9fd5d26
99. Newhouse PA, Potter A, Kelton M, Corwin J (2001) Nicotinic treatment of Alzheimer’s disease. Biol Psychiatry 49:268–278
100. Nones J, Costa A, Leal R, Gomes F, Trentin A (2012) The flavonoids hesperidin and rutin promote neural crest cell survival. Cell Tissue Res 350:305–315
101. Norris E, Giasson B, Hodara R, Xu S, Trojanowski J, Ischiropoulos H, Lee V (2005) Reversible inhibition of alphasynuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem 280:21212–21219
102. Palencia G, García E, Osorio-Rico L, Trejo-Solís C, Escamilla-Ramírez A, Sotelo J (2015) Neuroprotective effect of thalidomide on MPTP-induced toxicity. Neurotoxicology 47:82–87
103. Paris I et al (2011) Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line. Toxicol Sci 121:376–388
104. Parpura V et al (2012) Glial cells in (patho)physiology. J Neurochem 121:4–27. doi:10.1111/j.1471-4159.2012.07664.x
105. Paulsen BS, Souza CS, Chicaybam L, Bonamino MH, Bahia M, Costa SL, Borges HL, Rehen SK (2011) Agathisflavone enhances retinoic acid-induced neurogenesis and its receptors α and β in pluripotent stem cells. Stem Cells Dev 20:10. doi:10.1089/scd.2010.0446
106. Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A (2014) Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson’s disease. Toxicology 7:38–43
107. Perry V, Nicoll J, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193–201. doi:10.1038/nrneurol.2010.17
108. Peterson L, Flood P (2012) Oxidative stress and microglial cells in Parkinson’s disease. Mediat Inflamm 2012:401264. doi:10.1155/2012/401264
109. Qualls Z, Brown D, Ramlochansingh C, Hurley L, Tizabi Y (2014) Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson’s disease. Neurotox Res 25:81–89
110. Remya C, Dileep K, Tintu I, Variyar E, Sadasivan C (2014) Flavanone glycosides as acetylcholinesterase inhibitors: computational and experimental evidence. Indian J Pharm Sci 76:567–570
111. Renaud J, Chiasson K, Bournival J, Rouillard C, Martinoli M (2014) 17β-estradiol delays 6-OHDA-induce apoptosis by acting on Nur77 translocation from the nucleus to the cytoplasm. Neurotox Res 25:124–134
112. Rezai-Zadeh K, Ehrhart J, Bai Y, Sanberg P, Bickford P, Tan J, Douglas R (2008) Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J Neuroinflammation. doi:10.1186/1742-2094-5-41
113. Rodrigues J, Rinaldo D, Santos Ld, Vilegas W (2007) An unusual C6-C6″ linked flavonoid from Miconia cabucu (Melastomataceae). Phytochemistry 68:1781–1784
114. Rohn T (2012) Targeting alpha-synuclein for the treatment of Parkinson’s disease. CNS Neurol Disord Drug Targets 11:174–179
115. Sabogal-Guáqueta A, Muñoz-Manco J, Ramírez-Pineda J, Lamprea-Rodriguez M, Osorio E, Cardona-Gómez G (2015) The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model mice. Neuropharmacology 93:134–145
116. Sachdeva A, Kuhad A, Chopra K (2014) Naringin ameliorates memory deficits in experimental paradigm of Alzheimer’s disease by attenuating mitochondrial dysfunction. Pharmacol Biochem Behav 127:101–110
117. Santello M, Volterra A (2008) Synaptic modulation by astrocytes via Ca2+ -dependent glutamate release. Neuroscience 158:253–259. doi:10.1016/j.neuroscience.2008.03.039
118. Schapira A (2005) Present and future drug treatment for Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:1472–1478
119. Segura-Aguilar J, Kostrzewa R (2015) Neurotoxin mechanisms and processes relevant to Parkinson’s disease: an update. Neurotox Res 27:328–354
120. Selkoe D (1997) Alzheimer’s disease: genotypes, phenotypes, and treatments. Science 275:630–631
121. Silva A et al (2008) The flavonoid rutin induces astrocyte and microglia activation and regulates TNF-alpha and NO release in primary glial cell cultures. Cell Biol Toxicol 24:75–86
122. Simonyi A et al (2015) Inhibition of microglial activation by elderberry extracts and its phenolic components. Life Sci 1:30–38
123. Singhal N, Srivastava G, Patel D, Jain S, Singh M (2011) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson’s disease phenotype in the mouse. J Pineal Res 50:97–109
124. Smith Y, Wichmann T, Factor S, DeLong M (2012) Parkinson’s disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology 37:213–246
125. Sofroniew M, Vinters H (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:28. doi:10.1007/s00401-009-0619-8
126. Solanki I, Parihar P, Mansuri M, Parihar M (2015) Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv Nutr 6:64–72
127. SoniaAngeline M, Sarkar A, Anand K, Ambasta R, Kumar P (2013) Sesamol and naringenin reverse the effect of rotenone-induced PD rat model. Neuroscience 19:379–394
128. Souza C, Paulsen B, Devalle S, Costa S, Borges H, Rehen S (2015) Commitment of human pluripotent stem cells to a neural lineage is induced by the pro-estrogenic flavonoid apigenin. Adv Regen Biol 2:29244
129. Spencer J (2008) Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 67:238–252
130. Sutinen E, Pirttilä T, Anderson G, Salminen A, Ojala J (2012) Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells. J Neuroinflammation 16:199
131. Takasato Y, Rapoport S, Smith Q (1984) An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 247:484–493
132. Tardy M (2002) Role of laminin bioavailability in the astroglial permissivity for neuritic outgrowth. An Acad Bras Ciênc 74:683–690. doi:10.1590/S0001-37652002000400009
133. Taylor J, Main B, Crack P (2013) Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson’s disease. Neurochem Int 62:803–819
134. Terahara N (2015) Flavonoids in foods: a review. Nat Prod Commun 10:521–528
135. Thapa A, Woo ER, Chi EY, Sharoar MG, Jin HG, Shin SY, Park IS (2011) Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. Biochemistry 50:11. doi:10.1021/bi101731d
136. Verkhratsky A, Butt A (2007) Glial neurobiology: a textbook. 1st edn. doi:10.1002/9780470517796
137. Villa M et al (2013) One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity. Neurotox Res 24:94–101
138. Wang R, Sun Y, Huang H, Wang L, Chen J, Shen W (2015) Rutin, a natural flavonoid protects PC12 cells against sodium nitroprusside-induced neurotoxicity through activating PI3K/Akt/mTOR and ERK1/2 Pathway. Neurochem Res 40:1945–1953
139. Wei D, Tang J, Bai W, Wang Y, Zhang Z (2014) Ameliorative effects of baicalein on an amyloid-ß induced Alzheimer’s disease rat model: a proteomics study. Curr Alzheimer Res 11:869–881
140. Weinreb O, Mandel S, Amit T, Youdim M (2004) Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases. J Nutr Biochem 5:506–516. doi:10.1016/j.jnutbio.2004.05.002
141. Xiao-Lin Y et al (2015) Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress. Food Function 6:3296–3306
142. Xiong R, Siegel D, Ross D (2014) Quinone-induced protein handling changes: Implications for major protein handling systems in quinone-mediated toxicity. Toxicol Appl Pharmacol 280:285–295. doi:10.1016/j.taap.2014.08.014
143. Xu P et al (2014) Rutin improves spatial memory in Alzheimer’s disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation. Behav Brain Res 1:173–180
144. Xue X, Liu H, Qi L, Li X, Guo C, Gong D, Qu H (2014) Baicalein ameliorated the upregulation of striatal glutamatergic transmission in the mice model of Parkinson’s disease. Brain Res Bull 103:54–59
145. Yang C, Chung J, Yang G, Li C, Meng X, Lee M (2000) Mechanisms of inhibition of carcinogenesis by tea. BioFactors 13:73–78
146. Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J (2011) Silibinin: a novel inhibitor of Aβ aggregation. Neurochem Int 58:399–403
147. Yong-Kee C, Sidorova E, Hanif A, Perera G, Nash J (2012) Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson’s disease. Neurotox Res 21:185–194
148. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (2003) Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85:12. doi:10.1046/j.1471-4159.2003.01652.x
149. Youdim KA, Shukitt-Hale B, Joseph JA (2004) Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37:11. doi:10.1016/j.freeradbiomed.2004.08.002
150. Yu X, He G, Sun L, Lan X, Shi L, Xuan Z, Du GD (2012) Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism. Life Sci 91:5–13. doi:10.1016/j.lfs.2012.05.005
151. Zaminelli T et al (2014) Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson’s disease. Neurotox Res 26:351–362
152. Zafar K, Siegel D, Ross D (2006) A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition. Mol Pharmacol 70:1079–1086
153. Zang F, Fangcai L, Gang C (2014) Neuroprotective effect of apigenin in rats after contusive spinal cord injury. Neurol Sci 4:8–583
154. Zbarsky V, Datla K, Parkar S, Rai D, Aruoma O, Dexter D (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease. Free Radic Res 39:1119–1125
155. Zhang S et al (2013) Baicalein reduces ß-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model. J Neurosci Res 91:1239–1246
156. Zhao L, Wang J, Wang Y, Fa X (2013) Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model. Brain Res 1492:33–45. doi:10.1016/j.brainres.2012.11.019
157. Zhou Z, Lim T (2009) Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones. Free Radic Res 43:417–430